Feasibility of VECOPA, a dose-intensive chemotherapy regimen for children and adolescents with intermediate and advanced stage Hodgkin lymphoma: results of the GPOH-HD-2002/VECOPA pilot trial

Christine Mauz-KörholzDepartment of Pediatrics, Martin-Luther University Medical Center, Halle, GermanyCorrespondence[email protected]

Dirk HasencleverInstitute for Medical Informatics, Statistics and Epidemiology, Leipzig, Germany

Volker HolzendorfCenter for Clinical Trials, University of Leipzig, Leipzig, Germany

Matthias BernstädtDepartment of Pediatrics, Martin-Luther University Medical Center, Halle, Germany

Heribert JürgensDepartment of Pediatric Hematology and Oncology, Westfälische-Wilhelms-Universität, Münster, Germany

Stefan BurdachDepartment of Pediatrics, Technische Universität, München, Germany

Angelika EggertDepartment of Pediatric Hematology and Oncology, Charité Medical University, Berlin, Germany

Frank BertholdDepartment of Pediatric Hematology and Oncology, University of Cologne, Cologne, Germany

Hermann L. MüllerDepartment of Pediatric Hematology and Oncology, Klinikum Oldenburg, Oldenburg, Germany

Michael C. FrühwaldDepartment of Pediatrics, Klinikum Augsburg, Augsburg, Germany

Thomas KlingebielDepartment of Pediatric Hematology and Oncology, Wolfgang-Goethe-University Frankfurt, Frankfurt, Germany

Markus MetzlerDepartment of Pediatric Hematology and Oncology, University of Erlangen, Erlangen, Germany

Dieter KörholzDepartment of Pediatrics, Martin-Luther University Medical Center, Halle, Germany

Your download is now in progress and you may close this window